艾哈迈德青光眼阀植入术后长期视野结局
这项回顾性临床队列研究纳入173只接受艾哈迈德青光眼阀(AGV)植入术且术后随访至少2年、有至少4次合格术后视野的眼睛,用MD斜率、青光眼速率指数(GRI)和点wise线性回归(PLR)三种方法评估视野进展。结果显示眼压和青光眼用药数较基线显著下降,38只眼(22%)出现视野进展,101只眼(58%)在三种方法评估下均稳定;术后3个月后的峰值眼压与视野恶化相关,每增加1毫米汞柱风险增加7%。作者认为这是目前样本量最大的AGV术后长期视野结局系列,术后仍存在持续且显著的视野下降速率。
要点
- 眼压中位数从基线23.5 mm Hg降至末次随访12.8 mm Hg,青光眼用药数从3.3±1.2降至2.2±1.4。
- 38只眼(22%)出现视野进展,101只眼(58%)经三种方法评估均为稳定。
- 术后3个月后的峰值眼压与视野恶化相关,每增加1 mm Hg风险增加7%。
核心结论
- 作者认为这是已发表的最大样本量系列,报告青光眼引流装置植入术后长期视野结局,AGV术后仍存在持续且显著的视野下降速率。
研究设计与样本
- 回顾性临床队列研究,纳入接受AGV植入术且至少有4次合格术后视野、随访至少2年的患者,共173只眼。
主要发现
- 眼压中位数(四分位距)从基线23.5(12.1)mm Hg降至末次随访12.8(4.0)mm Hg,青光眼用药数(均值±标准差)从3.3±1.2降至2.2±1.4。
- 38只眼(22%)出现视野进展,101只眼(58%)经三种方法评估均为稳定,占全部眼的80%。
- MD和GRI评估的视野下降速率中位数(四分位距)分别为-0.30(0.8)dB/年和-2.30(10.6)(满分为-100)。
- 比较手术前后进展时,三种方法均未达统计学显著。
- 术后3个月后的峰值眼压与视野恶化相关,每增加1 mm Hg风险增加7%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To measure visual field (VF) rates of change after Ahmed Glaucoma Valve (AGV) implantation and to investigate risk factors for progression. DESIGN: Retrospective, clinical cohort study. METHODS: Patients who underwent AGV implantation with at least 4 eligible postoperative VFs and 2 years of follow-up were included. Baseline, intraoperative, and postoperative data were collected. VF progression was explored with 3 methods: mean deviation (MD) rate; glaucoma rate index (GRI); and pointwise linear regression (PLR). For a subset of eyes with sufficient preoperative and postoperative VFs, rates were compared between the 2 periods. RESULTS: A total of 173 eyes were included. The intraocular pressure (IOP) and number of glaucoma medications were significantly reduced from a median (interquartile range [IQR]) of 23.5 (12.1) mm Hg at baseline to 12.8 (4.0) mm Hg at final follow-up, and from (mean ± SD) 3.3 ± 1.2 to 2.2 ± 1.4, respectively. A total of 38 eyes (22%) showed VF progression, and 101 eyes (58%) were stable as assessed by all 3 methods, which accounted for 80% of all eyes. The rate of VF decline by MD and GRI was a median (IQR) of -0.30 (0.8) dB/y and -2.30 (10.6) (of -100), respectively. When comparing progression before and after surgery, the reduction was not statistically significant with any of the methods. The peak IOP (after 3 postoperative months) was associated with VF deterioration, with a 7% increase in risk per each additional millimeter of mercury (mm Hg). CONCLUSIONS: To our knowledge, this is the largest published series reporting long-term VF outcomes after glaucoma drainage device implantation. There is a continued, significant rate of VF decline after AGV surgery.
引用
- Khaliliyeh D, De Gainza A, Morales E, et al. Long-Term Visual Field Outcomes After Ahmed Glaucoma Valve Implantation. Am J Ophthalmol. 2023. PMID: 36868342. doi:10.1016/j.ajo.2023.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。